Study Description: The aim of this study is to develop new respiratory papillomatosis cell lines from primary recurrent respiratory papillomatosis (RRP) tissues. These cell lines will be used in future laboratory-based studies to develop and extend treatment approaches to target (currently unknown) weaknesses or dependencies in RRP.
Principal Investigator: J. Drew Prosser
Eligibility Criteria: Patients who carry a known diagnosis of recurrent respiratory papillomatosis (RRP) and who are undergoing laryngoscopic procedures at GRU
Compensation: No, subjects will not be compensated.
If you don't see specific studies that interest you, please submit your contact information for future studies.